InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (10 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
10
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Hanson Kristopher, Chief Executive Officer. Insider active across 3 companies, notably PhaseBio Pharmaceuticals Inc. In total, 17 disclosures have been published. Breakdown: 0 buy · 10 sells. Total volume traded: €572k. Activity tracked since 20 May 2021. The latest transaction was disclosed on 17 August 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Hanson Kristopher
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations17 total
7,730 shares0Voting Common StockSEC:0001789970-26-000014:0
5,103 shares@ US$36.990.011% mcap10.9% of flowVoting Common StockSEC:0001789970-26-000012:1
2,147 shares@ US$36.000.0045% mcap4.5% of flowVoting Common StockSEC:0001789970-26-000012:0
3,331 shares@ US$37.260.0072% mcap7.2% of flowVoting Common StockSEC:0001789970-26-000012:4
4,776 shares@ US$36.450.010% mcap10.0% of flowVoting Common StockSEC:0001789970-26-000012:3
10 shares@ US$37.540.0000% mcap0.0% of flowVoting Common StockSEC:0001789970-26-000012:2
11 shares@ US$37.960.0000% mcap0.0% of flowVoting Common StockSEC:0001789970-26-000012:5
1,130 shares@ US$37.900.0025% mcap2.5% of flowVoting Common StockSEC:0001789970-26-000012:6
1,529 shares@ US$26.800.0025% mcap83.4% of flowVoting Common StockSEC:0001789970-26-000006:0
73 shares@ US$27.010.0001% mcap4.0% of flowVoting Common StockSEC:0001789970-26-000006:1
225 shares@ US$27.490.0004% mcap12.6% of flowVoting Common StockSEC:0001789970-26-000006:2
7,730 shares0Voting Common StockSEC:0001789970-26-000004:0
26,007 shares@ US$17.9890.4% of flowVoting Common StockSEC:0001789970-26-000002:0
27,098 shares0Voting Common StockSEC:0001789970-25-000008:0
4,831 shares@ US$0.681337.3% of flowCommon StockSEC:0001169245-22-000076:0
1,545 shares@ US$2.0132.8% of flowCommon StockSEC:0001169245-21-000126:0
1,088 shares@ US$2.8029.9% of flowCommon StockSEC:0001169245-21-000042:0
17 of 17 declarations
About Hanson Kristopher
Hanson Kristopher is Vice President, General Counsel and Chief Executive Officer. The 16 filings cover MapLight Therapeutics, Inc. and PhaseBio Pharmaceuticals Inc, with, in the recent sampled filings, 0 EUR of purchases and 572284 EUR of sales between 2021-05-24 and 2026-07-17. The top filings include 393724.1475435746 EUR on 2026-01-29, then 165013.9628862683 EUR, 151767.4808698661 EUR, 108201.7682103392 EUR, 67568.66521755354 EUR and 37417.95098614814 EUR on 2026-07-17.
